IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma
Academic Article
Publication Date:
2023
Short description:
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma / Pirosa, M.C., Sassone, M., Kiesewetter, B., Guillermo, A.L., Devizzi, L., Domenech, E.D., Tucci, A., Mannina, D., Merli, M., Salar, A., Visco, C., Esposito, F., Bonomini, L., Zucca, E., Ferreri, A.J.M., Raderer, M.. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 108:6(2023), pp. 1671-1675. [10.3324/haematol.2022.281963]
Iris type:
1.1.2. Articolo in Rivista - Letter, Note
List of contributors:
Pirosa, M. C.; Sassone, M.; Kiesewetter, B.; Guillermo, A. L.; Devizzi, L.; Domenech, E. D.; Tucci, A.; Mannina, D.; Merli, M.; Salar, A.; Visco, C.; Esposito, F.; Bonomini, L.; Zucca, E.; Ferreri, A. J. M.; Raderer, M.
Published in: